After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.
A MAHA commission report on child health cited several studies that could not be verified, leading to corrections and questions about sourcing accuracy.
Harvard Business School revokes tenure from Francesca Gino following data fraud allegations and an 18-month institutional investigation into research misconduct.
Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.